440 results on '"Ward, Leanne M."'
Search Results
2. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults
3. Bone Fragility Disorders in Childhood and Adolescence
4. Correction: Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults
5. Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI
6. Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy
7. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
8. Part 2: When Should Bisphosphonates Be Used in Children with Chronic Illness Osteoporosis?
9. Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring?
10. Burosumab vs conventional therapy in children with X-linked hypophosphatemia : results of the open-label, phase 3 extension period
11. Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
12. A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence
13. Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022
14. Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period
15. Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document
16. New developments in the management of achondroplasia
17. Osteoporosis: Diagnosis and Management
18. The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position
19. Beyond Bone Mineral Density: The Impact of Childhood Cancer and Its Treatment on Bone Structure and Strength
20. Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document.
21. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults
22. Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome
23. X-linked hypophosphatemia caused by a deep intronic variant in PHEX identified by PCR-based RNA analysis of urine-derived cells
24. X-linked hypophosphatemia, fibroblast growth factor 23 signaling, and craniosynostosis
25. Vertebral body reshaping after fractures: an important index of recovery in glucocorticoid-treated children
26. Disorders of Calcium, Phosphorus, and Bone Metabolism During Fetal and Neonatal Development
27. Physiology of Calcium, Phosphorus, and Bone Metabolism During Fetal and Neonatal Development
28. Contributors
29. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan
30. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management
31. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
32. Increased bone matrix mineralization in treatment-naïve children with inflammatory bowel disease
33. Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy
34. Impacting Children’s Physical and Mental Health through Kinesiology Support in Clinical Care: A Randomized Controlled Trial Protocol
35. Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives
36. RNA Sequencing of Urine‐Derived Cells for the Characterization and Diagnosis of Osteogenesis Imperfecta
37. RANKL Inhibition Reduces Cardiac Hypertrophy in mdx Mice and Possibly in Children with Duchenne Muscular Dystrophy
38. Bone Mineral Density as a Predictor of Vertebral Fractures in Children and Adolescents
39. Vertebral Body Reshaping after Fractures: An Important Index of Recovery in Glucocorticoid-Treated Children
40. Bisphosphonates in Glucocorticoid-Treated Patients With Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence.
41. Anabolic Therapy for the Treatment of Osteoporosis in Childhood
42. Burosumab Versus Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Sub-group Analysis by Dose Level
43. Bone health in childhood and adolescence: an overview on dual-energy X-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries
44. Burosumab Versus Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia : A Sub-group Analysis by Dose Level
45. The Radiology of Vertebral Fractures in Childhood Osteoporosis Related to Glucocorticoid Administration
46. Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy
47. Growth, pubertal development, and skeletal health in boys with Duchenne Muscular Dystrophy
48. From “ACAN” to “I CAN”: Restoring wellness in a boy with severe osteochondritis dissecans through diagnostic precision combined with optimal medical, surgical and rehabilitation management
49. A randomized, cross-over trial comparing the effect of innovative robotic gait training and functional clinical therapy in children with cerebral palsy; a protocol to test feasibility
50. Incidence and characteristics of vitamin D deficiency rickets in New Zealand children: a New Zealand Paediatric Surveillance Unit study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.